SEC Waives $40M Fine For Mallinckrodt In Medicaid Scheme
By Henrik Nilsson · November 30, 2023, 10:14 PM EST
The U.S. Securities and Exchange Commission announced Thursday that it has waived a $40 million civil penalty against pharmaceutical company Mallinckrodt for overcharging Medicaid for one of its flagship drugs, saying...
To view the full article, register now.